Mark For: OPTISENSE™ trademark registration is intended to cover the category of
Research | OneLook Acronym Finder |
Serial Number | 76311797 |
Mark Literal Elements | OPTISENSE |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 106 2005-02-09 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Dana R. Kaplan, Esq. |
Attorney Docket Number | 12472/53 |
Law Office Assigned | L60 |
Employee Name | FROMM, MARTHA L |
2001-09-12 | Application Filed |
2002-11-26 | Published |
2002-11-26 | Published for Opposition |
2005-02-09 | Location: TMEG LAW OFFICE 106 |
2005-02-19 | Abandon |
2005-02-19 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
2005-02-19 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Party: | GENTA INCORPORATED |
Address | Two Connell Drive BERKELEY HEIGHTS, NEW JERSEY UNITED STATES 07922 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
(ABANDONED)
IC 042. US 100 101. G & S: Pharmaceutical research and development in the field of identifying target sequences found in nucleic acids for purposes of inhibition of known biological processes or for repair of certain nucleic acid sequences and in the field of forming antisense nucleotide sequences for use in pharmaceutical development
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Pharmaceutical research and development in the field of identifying target sequences found in nucleic acids for purposes of inhibition of known biological processes or for repair of certain nucleic acid sequences and in the field of forming antisense nucleotide sequences for use in pharmaceutical development |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2005-09-28 | |
ABANDONMENT - NO USE STATEMENT FILED | 2005-09-28 | 46996 |
ASSIGNED TO EXAMINER | 2005-02-09 | 74676 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2004-12-10 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2004-12-10 | |
SOU EXTENSION 3 GRANTED | 2004-10-20 | 65362 |
PETITION TO REVIVE-GRANTED | 2004-10-08 | 66600 |
TEAS EXTENSION RECEIVED | 2004-08-12 | |
SOU EXTENSION 3 FILED | 2004-08-12 | 65362 |
PETITION TO REVIVE-RECEIVED | 2004-06-30 | |
FAX RECEIVED | 2004-06-30 | |
ABANDONMENT - NO USE STATEMENT FILED | 2004-05-24 | |
SOU EXTENSION 2 GRANTED | 2004-05-10 | 65362 |
TEAS EXTENSION RECEIVED | 2004-02-18 | |
SOU EXTENSION 2 FILED | 2004-02-18 | |
SOU EXTENSION 1 GRANTED | 2003-08-21 | |
TEAS EXTENSION RECEIVED | 2003-08-11 | |
SOU EXTENSION 1 FILED | 2003-08-11 | |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2003-02-18 | |
PUBLISHED FOR OPPOSITION | 2002-11-26 | |
NOTICE OF PUBLICATION | 2002-11-06 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-09-24 | |
LETTER OF SUSPENSION MAILED | 2002-06-28 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-06-13 | |
NON-FINAL ACTION MAILED | 2001-12-19 | |
ASSIGNED TO EXAMINER | 2001-12-06 | 69775 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.